Resistance-Conferring Mycobacterial Mutations and Quantification of Early Bactericidal Activity.
作者信息
le Roux Solomon P, Upton Caryn, Vanker Naadira, Dooley Kelly E, Diacon Andreas H
机构信息
TASK Applied Science Cape Town, South Africa.
Johns Hopkins University Baltimore, Maryland and.
出版信息
Am J Respir Crit Care Med. 2021 Mar 1;203(5):635-637. doi: 10.1164/rccm.202007-2740LE.
Abstract
摘要
相似文献
1
Resistance-Conferring Mycobacterial Mutations and Quantification of Early Bactericidal Activity.赋予耐药性的分枝杆菌突变及早期杀菌活性的定量分析
Am J Respir Crit Care Med. 2021 Mar 1;203(5):635-637. doi: 10.1164/rccm.202007-2740LE.
2
Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.南非自由州省与耐多药结核病相关的异烟肼耐药突变体的流行情况。
S Afr Med J. 2019 Aug 28;109(9):659-664. doi: 10.7196/SAMJ.2019.v109i9.13730.
3
Occurrence of diverse mutations in isoniazid- and rifampicin-resistant Mycobacterium tuberculosis isolates from autochthonous and immigrant populations of Saudi Arabia.来自沙特阿拉伯本地人和移民群体的耐异烟肼和利福平结核分枝杆菌分离株中多种突变的发生情况。
Microb Drug Resist. 2014 Dec;20(6):623-31. doi: 10.1089/mdr.2014.0065.
4
Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia.在埃塞俄比亚亚的斯亚贝巴，对新诊断的肺结核患者分离的结核分枝杆菌进行了多药耐药模式和相关基因突变的分子检测。
PLoS One. 2020 Aug 4;15(8):e0236054. doi: 10.1371/journal.pone.0236054. eCollection 2020.
5
Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates in Uruguay.乌拉圭异烟肼耐药结核分枝杆菌分离株的分子分析。
Int J Tuberc Lung Dis. 2012 Jul;16(7):947-9. doi: 10.5588/ijtld.11.0559. Epub 2012 Apr 9.
6
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.异烟肼耐药突变及耐多药结核分枝杆菌进化的群体遗传学研究
Antimicrob Agents Chemother. 2006 Aug;50(8):2640-9. doi: 10.1128/AAC.00112-06.
7
Differences in rpoB, katG and inhA mutations between new and previously treated tuberculosis cases using the GenoType MTBDRplus assay.采用 GenoType MTBDRplus 检测方法比较新发病例和复治病例中 rpoB、katG 和 inhA 基因突变的差异。
Infect Genet Evol. 2018 Apr;59:48-50. doi: 10.1016/j.meegid.2018.01.022. Epub 2018 Feb 4.
8
Drug resistant in Oman: resistance-conferring mutations and lineage diversity.阿曼的耐药性：耐药相关突变和谱系多样性。
PeerJ. 2022 Jul 28;10:e13645. doi: 10.7717/peerj.13645. eCollection 2022.
9
High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations.高水平耐异烟肼和乙硫异烟胺与利什曼家族的耐多药结核分枝杆菌中的 inhA 双重突变有关。
J Antimicrob Chemother. 2013 Aug;68(8):1728-32. doi: 10.1093/jac/dkt090. Epub 2013 Mar 28.
10
Loss-of-function mutations in do not confer delamanid, ethionamide, isoniazid, or pretomanid resistance in .在 中，功能丧失突变不会赋予德拉马尼、乙硫异烟胺、异烟肼或丙硫异烟胺耐药性。
Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0109623. doi: 10.1128/aac.01096-23. Epub 2023 Dec 1.
引用本文的文献
1
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial.高剂量异烟肼缺乏对 katG 突变介导的耐异烟肼结核病的早期杀菌活性：一项随机、Ⅱ期临床试验。
Am J Respir Crit Care Med. 2024 Aug 1;210(3):343-351. doi: 10.1164/rccm.202311-2004OC.
2
Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease.结核病和非结核分枝杆菌肺部疾病的治疗进展。
Nat Rev Drug Discov. 2024 May;23(5):381-403. doi: 10.1038/s41573-024-00897-5. Epub 2024 Feb 28.
3
Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development.用于支持结核病药物研发的阳性时间和菌落形成单位的联合定量结核病生物标志物模型。
Front Pharmacol. 2023 Mar 14;14:1067295. doi: 10.3389/fphar.2023.1067295. eCollection 2023.
4
A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial.高剂量异烟肼对耐多药结核病杀菌活性的半机制模型：一项随机临床试验的结果
Am J Respir Crit Care Med. 2021 Dec 1;204(11):1327-1335. doi: 10.1164/rccm.202103-0534OC.
本文引用的文献
1
Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical Trial.不同异烟肼剂量对耐多药结核病的早期杀菌活性（事后回顾）：一项随机、开放标签的临床试验
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1416-1424. doi: 10.1164/rccm.201910-1960OC.
2
Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid Culture.基于模型的分子细菌载量检测与液体培养阳性时间的关系。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.00652-19. Print 2019 Oct.
3
Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.痰中脂阿拉伯甘露聚糖检测用于肺结核患者细菌负荷和治疗反应的分析验证：两项队列研究评估。
PLoS Med. 2019 Apr 12;16(4):e1002780. doi: 10.1371/journal.pmed.1002780. eCollection 2019 Apr.
4
Machine learning and structural analysis of Mycobacterium tuberculosis pan-genome identifies genetic signatures of antibiotic resistance.机器学习和结核分枝杆菌泛基因组结构分析鉴定抗生素耐药的遗传特征。
Nat Commun. 2018 Oct 17;9(1):4306. doi: 10.1038/s41467-018-06634-y.
5
Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum.从痰标本中 DNA 清除情况的纵向分析看，是否真的需要一种新的治疗模式来发现可培养的差异结核分枝杆菌？
BMC Infect Dis. 2018 Jul 3;18(1):293. doi: 10.1186/s12879-018-3213-7.
6
Evaluation of a Urine-Based Rapid Molecular Diagnostic Test with Potential to Be Used at Point-of-Care for Pulmonary Tuberculosis: Cape Town Cohort.基于尿液的快速分子诊断检测在即时检测肺结核方面的应用评估：开普敦队列研究。
J Mol Diagn. 2018 Mar;20(2):215-224. doi: 10.1016/j.jmoldx.2017.11.005. Epub 2017 Dec 18.
7
In vitro and in vivo fitness costs associated with Mycobacterium tuberculosis RpoB mutation H526D.与结核分枝杆菌RpoB突变H526D相关的体外和体内适应性代价。
Future Microbiol. 2017 Jul;12(9):753-765. doi: 10.2217/fmb-2017-0022. Epub 2017 Mar 27.
8
The fitness costs of antibiotic resistance mutations.抗生素耐药性突变的适应代价。
Evol Appl. 2015 Mar;8(3):273-83. doi: 10.1111/eva.12196. Epub 2014 Aug 27.
9
Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.评估 Xpert MTB/RIF 检测作为结核病治疗早期痰生物标志物的敏感性和特异性。
Lancet Respir Med. 2013 Aug;1(6):462-70. doi: 10.1016/S2213-2600(13)70119-X. Epub 2013 Jul 1.
10
Mapping the fitness of Mycobacterium tuberculosis strains: a complex picture.绘制结核分枝杆菌菌株的适应性图谱：一幅复杂的图景。
J Med Microbiol. 2010 Dec;59(Pt 12):1533-1535. doi: 10.1099/jmm.0.019091-0. Epub 2010 Aug 19.
Zotero 插件